Records containing: Major Depressive Disorder
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-04-05Self-guided Treatment for Adolescents/Adults Navigating Depression (STAND-MDD): A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2024-04-04Investigating Biological Markers, Targets, and Intervention for Mood Disorders
-
CLINICAL_TRIALS study record update · 2024-04-03TBS Treatment for Treatment-Resistant Depression: a Randomized, Sham-Controlled Trial
-
CLINICAL_TRIALS study record update · 2024-04-03Brain Oscillation Synchronized Stimulation of the Frontal Cortex: Randomized Controlled Trial Comparing Frontal Theta-oscillation Synchronized Repetitive TMS With Standard TMS in Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2024-04-02Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: A Randomized Phase II Clinical Trial Comparing One Versus Two Psychedelic Doses of Psilocybin (PSI-1V2)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-04-02Mini Theta Burst TMS to Promote Brain Plasticity Indexed by fMRI in MDD Patients
-
CLINICAL_TRIALS study record update · 2024-04-01An Open-label, Adaptive Design Study in Healthy Male Participants to Characterize the Occupancy of NR2B Subunit Containing NMDA Receptors in the Brain Following a Single Intravenous Dose of MIJ821 Using Positron Emission Tomography (PET) With the Radioligand [11C]Me-NB1
-
CLINICAL_TRIALS study record update · 2024-04-01Agomelatine Augmentation in Early-Nonresponsive Patients With Major Depressive Disorder Receiving SSRIs or SNRIs: a Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial
-
CLINICAL_TRIALS study record update · 2024-03-27A Double-blind, Randomised, Placebo-controlled Study of Intravenous Doses of SPL026 (DMT Fumarate), a Serotonergic Psychedelic, in Healthy Subjects (Part A) and Patients With Major Depressive Disorder (Part B)
-
CLINICAL_TRIALS study record update · 2024-03-26A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment of Major Depressive Disorder (The RELIANCE-I Study)
-
CLINICAL_TRIALS study record update · 2024-03-26A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of REL-1017 Monotherapy for Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2024-03-26Exploring Blood Plasma Metabolomics: Unraveling the Metabolic Landscape in Treatment-Resistant Adolescent Depression
-
CLINICAL_TRIALS study record update · 2024-03-26The Relationship Between Emotion Regulation and Psychiatric Disorder in Youth - From a Psychosocial Developmental Aspect.
-
CLINICAL_TRIALS study record update · 2024-03-25A Phase I/IIa, Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Relative Bioavailability and Food Effect Cohort to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Oral Doses of CYB003 in Healthy Participants With and Without Major Depressive Disorder (MDD)
-
CLINICAL_TRIALS study record update · 2024-03-25The Efficacy and Prediction of Deep Brain Stimulation for Treatment-resistant Depression
-
CLINICAL_TRIALS study record update · 2024-03-25Acceptability and Feasibility of Transcranial Magnetic Stimulation (TMS) for Depression in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2024-03-22Effectiveness of an Integrated Care Pathway for Adolescent Depression: A Quasi-experimental, Multi-site, Cluster Controlled Trial (Edited on March 7th, 2024)
-
CLINICAL_TRIALS study record update · 2024-03-22Open-label, Cross-over Study of IM and IV Doses of SPL026 in Healthy, Psychedelic-experienced Participants (Part A: IM and IV Doses) and Participants With Little to no Psychedelic Experience (Part B: IM Dose Only)
-
CLINICAL_TRIALS study record update · 2024-03-15The Biological Specificity of Acupoints Between Major Depressive Disorder Patients and Healthy Controls: A Prospective, Assessor-blinded, Comparative Study
-
CLINICAL_TRIALS study record update · 2024-03-13Sex, Hormones and GABA in Stress Induced Anhedonia in Depression
-
CLINICAL_TRIALS study record update · 2024-03-12Adjusting Immune Activation to Reinstate Neural Plasticity and Promote the Beneficial Effect of Non-pharmacological Interventions
-
CLINICAL_TRIALS study record update · 2024-03-12Inflammatory Control of Antidepressant Efficacy: a Pharmaco-epigenetic Approach
-
CLINICAL_TRIALS study record update · 2024-03-08Assessing the Role of Repetitive Transcranial Magnetic Stimulation on Aberrant Executive Function in the Context of Major Depressive Disorder in Adult Outpatients Seeking Treatment for Alcohol Use Disorder
-
CLINICAL_TRIALS study record update · 2024-03-06A Remote Electronically Delivered Integrated Care Pathway for Adolescents With Major Depressive Disorder: A Feasibility Study
-
CLINICAL_TRIALS study record update · 2024-03-05Prospective, Multicenter Non-randomised, Open-label Study Evaluating the Correlation Between Physiological Data Measured by a Portable Sensor and Psychometric Assessment